Objective: To investigate the effect of reduced extracellular dopamine (DA) levels on refractive development in guinea pigs by periocularly injecting a noncompetitive vesicular monoamine transporter 2 (VMAT2) antagonist, tetrabenazine (TBZ). Methods: Three-week-old guinea pigs were randomly divided into 8 groups in this experimental group. Seventy-eight animals were raised under normal vision (NV) and divided into the following groups: the normal control (NC, n=18), vehicle (dimethyl sulfoxide,NV+DMSO, n=18), low-dose TBZ (NV+30 ng, n=22), and high-dose TBZ (NV+300ng, n=20) groups.Seventy-four animals raised with form deprivation (FD) were divided into the following groups: FD (n=17),FD+DMSO (n=18), FD+30 ng (n=21) and FD+300 ng (n=18) groups. DMSO, TBZ (30 ng or 300 ng) was periocularly injected into the right eyes daily in 100 µl of 0.1% DMSO. Refractive changes were evaluated prior to treatment and 2 weeks and 4 weeks after treatments. p-CREB immunofluorescent staining evaluated DA receptor activation. Data were analyzed using one-way ANOVA and an independent samples
t-test. Results: After 2 weeks of TBZ injections, guinea pigs developed myopia in the NV environment.The inter-ocular difference in refraction for NV+DMSO, NV+30 ng and NV+300 ng were 0.04 ± 0.31 D,-0.90 ± 0.84 D and -0.75 ± 0.66 D, respectively (F=11.133, P < 0.001). The vitreous chamber depth in these three groups was increased consistently with the inter-ocular differences of -0.01 ± 0.03 mm,0.02 ± 0.03 mm and 0.02 ± 0.04 mm (F=6.001, P=0.004). Four weeks of TBZ injection could not further increase myopia. The inter-ocular differences between NV+DMSO, NV+30 ng and NV+300 ng were -0.06 ± 0.41 D, -1.14 ± 1.61 D and -0.84 ± 1.41 D, respectively (F=3.569, P=0.035). Four weeks of TBZ application significantly reduced the number of cells that expressed p-CREB in the retinal ganglion cell layer and inner nuclear layer (t=4.825, P=0.003, t=8.109, P < 0.001). TBZ injections did not affect the development of form deprivation myopia (FDM) in guinea pigs. Conclusions: The VMAT2 function inhibition by TBZ induces myopia in guinea pigs raised in NV but does not affect the development of FDM. This effect might be mediated by a reduced release of monoamine transmitters, especially DA.
祝瑞雪,裴晓梦,胡洋,支知娜,张森,周翔天,瞿佳. 抑制单胺囊泡转运体功能在豚鼠屈光发育及形觉剥夺性近视中的作用[J]. 中华眼视光学与视觉科学杂志, 2018, 20(6): 326-332.
Ruixue Zhu,Xiaomeng Pei,Yang Hu,Zhina Zhi,Sen Zhang,Xiangtian Zhou,Jia Qu. The Effect of Blocking Vesicular Monoamine Transporter 2 on Refractive Development and Ocular Growth in Normal and Form-Deprived Myopic Guinea Pigs. Chinese Journal of Optometry Ophthalmology and Visual science, 2018, 20(6): 326-332. DOI: 10.3760/cma.j.issn.1674-845X.2018.06.002
Feldkaemper M, Schaeffel F. An updated view on the role of dopamine in myopia. Exp Eye Res, 2013, 114: 106-119. DOI:10.1016/j.exer.2013.02.007.
[2]
Mathis U, Schaeffel F. Glucagon-related peptides in the mouse retina and the effects of deprivation of form vision. Graefes Arch Clin Exp Ophthalmol, 2007, 245(2): 267-275. DOI: 10.1007/s00417-006-0282-x.
[3]
Hsi E, Chen KC, Chang WS, et al. A functional polymorphism at the FGF10 gene is associated with extreme myopia. Invest Ophthalmol Vis Sci, 2013, 54(5): 3265-3271. DOI: 10.1167/iovs.13-11814.
[4]
Lin HJ, Wan L, Chen WC, et al. Muscarinic acetylcholine receptor 3 is dominant in myopia progression. Invest Ophthalmol Vis Sci, 2012, 53(10): 6519-6525. DOI: 10.1167/iovs.11-9031.
[5]
Nickla DL, Lee L, Totonelly K. Nitric oxide synthase inhibitors prevent the growth-inhibiting effects of quinpirole. Optom Vis Sci,2013, 90(11): 1167-1175. DOI: 10.1097/OPX.0000000000000041.
[6]
Stone RA, Lin T, Laties AM, et al. Retinal dopamine and form- deprivation myopia. Proc Natl Acad Sci USA, 1989, 86(2): 704-706.
[6]
Stone RA, Lin T, Laties AM, et al. Retinal dopamine and form- deprivation myopia. Proc Natl Acad Sci USA, 1989, 86(2): 704-706.
[7]
Dong F, Zhi Z, Pan M, et al. Inhibition of experimental myopia by a dopamine agonist: different effectiveness between form deprivation and hyperopic defocus in guinea pigs. Mol Vis,
[7]
Dong F, Zhi Z, Pan M, et al. Inhibition of experimental myopia by a dopamine agonist: different effectiveness between form deprivation and hyperopic defocus in guinea pigs. Mol Vis,
20
11, 17: 2824-2834.
20
11, 17: 2824-2834.
[8]
Rohrer B, Spira AW, Stell WK. Apomorphine blocks form- deprivation myopia in chickens by a dopamine D2-receptor mechanism acting in retina or pigmented epithelium. Vis
[8]
Rohrer B, Spira AW, Stell WK. Apomorphine blocks form- deprivation myopia in chickens by a dopamine D2-receptor mechanism acting in retina or pigmented epithelium. Vis
Neurosci, 1993, 10(3): 447-453.
[9]
Schmid KL, Wildsoet CF. Inhibitory effects of apomorphine and atropine and their combination on myopia in chicks. Optom Vis Sci, 2004, 81(2): 137-147. DOI: 10.1097/00006324-200402000-00012.
Neurosci, 1993, 10(3): 447-453.
[9]
Schmid KL, Wildsoet CF. Inhibitory effects of apomorphine and atropine and their combination on myopia in chicks. Optom Vis Sci, 2004, 81(2): 137-147. DOI: 10.1097/00006324-200402000-00012.
[10]
Iuvone PM, Tigges M, Stone RA, et al. Effects of apomorphine,a dopamine receptor agonist, on ocular refraction and axial elongation in a primate model of myopia. Invest Ophthalmol Vis Sci, 1991, 32(5): 1674-1677.
[11]
Hirasawa H, Betensky RA, Raviola E. Corelease of dopamine and GABA by a retinal dopaminergic neuron. J Neurosci, 2012, 32(38):13281-13291. DOI: 10.1523/JNEUROSCI.2213-12.2012.
[10]
Iuvone PM, Tigges M, Stone RA, et al. Effects of apomorphine,a dopamine receptor agonist, on ocular refraction and axial elongation in a primate model of myopia. Invest Ophthalmol Vis Sci, 1991, 32(5): 1674-1677.
[11]
Hirasawa H, Betensky RA, Raviola E. Corelease of dopamine and GABA by a retinal dopaminergic neuron. J Neurosci, 2012, 32(38):13281-13291. DOI: 10.1523/JNEUROSCI.2213-12.2012.
[12]
Witkovsky P, Arango-Gonzalez B, Haycock JW, et al. Rat retinal dopaminergic neurons: Differential maturation of somatodendritic and axonal compartments. J Comp Neurol,
20
05, 481(4): 352-362. DOI: 10.1002/cne.20389.
[13]
Pettibone DJ, Totaro JA, Pflueger AB. Tetrabenazine-induced depletion of brain monoamines: Characterization and interaction with selected antidepressants. Eur J Pharmacol, 1984, 102(3-4):425-430. DOI: 10.1016/0014-2999(84)90562-4.
[12]
Witkovsky P, Arango-Gonzalez B, Haycock JW, et al. Rat retinal dopaminergic neurons: Differential maturation of somatodendritic and axonal compartments. J Comp Neurol,
20
05, 481(4): 352-362. DOI: 10.1002/cne.20389.
[13]
Pettibone DJ, Totaro JA, Pflueger AB. Tetrabenazine-induced depletion of brain monoamines: Characterization and interaction with selected antidepressants. Eur J Pharmacol, 1984, 102(3-4):425-430. DOI: 10.1016/0014-2999(84)90562-4.
[14]
Reches A, Burke RE, Kuhn CM, et al. Tetrabenazine, an amine-depleting drug, also blocks dopamine receptors in rat brain. J Pharmacol Exp Ther, 1983, 225(3): 515-521.
[15]
Hadjiconstantinou M, Cohen J, Neff NH. Epinephrine:A potential neurotransmitter in retina. J Neurochem, 1983, 41(5):1440-1444. DOI: 10.1111/j.1471-4159.1983.tb00843.x.
[16]
George A, Schmid KL, Pow DV. Retinal serotonin, eye growth and myopia development in chick. Exp Eye Res, 2005, 81(5):616-625. DOI: 10.1016/j.exer.2005.03.021.
[17]
Li B, Luo X, Li T, et al. Effects of constant flickering light on refractive status, 5-HT and 5-HT2A receptor in guinea pigs.PLoS One, 2016, 11(12): e0167902. DOI: 10.1371/journal.pone.0167902.
[18]
Yang JW, Xu YC, Sun L, et al. 5-hydroxytryptamine level and 5-HT2A receptor mRNA expression in the guinea pigs eyes with spectacle lens-induced myopia. Int J Ophthalmol, 2010, 3(4):299-303. DOI: 10.3980/j.issn.2222-3959.2010.04.05.
[19]
Chanut E, Labarthe B, Lacroix B, et al. Variations of dopamine,serotonin, and amino acid concentrations in Noda epileptic rat (NER) retina. Brain Res, 2006, 1070(1): 56-64. DOI: 10.1016/j.brainres.2005.11.032.
Reches A, Burke RE, Kuhn CM, et al. Tetrabenazine, an amine-depleting drug, also blocks dopamine receptors in rat brain. J Pharmacol Exp Ther, 1983, 225(3): 515-521.
[15]
Hadjiconstantinou M, Cohen J, Neff NH. Epinephrine:A potential neurotransmitter in retina. J Neurochem, 1983, 41(5):1440-1444. DOI: 10.1111/j.1471-4159.1983.tb00843.x.
[16]
George A, Schmid KL, Pow DV. Retinal serotonin, eye growth and myopia development in chick. Exp Eye Res, 2005, 81(5):616-625. DOI: 10.1016/j.exer.2005.03.021.
[17]
Li B, Luo X, Li T, et al. Effects of constant flickering light on refractive status, 5-HT and 5-HT2A receptor in guinea pigs.PLoS One, 2016, 11(12): e0167902. DOI: 10.1371/journal.pone.0167902.
[18]
Yang JW, Xu YC, Sun L, et al. 5-hydroxytryptamine level and 5-HT2A receptor mRNA expression in the guinea pigs eyes with spectacle lens-induced myopia. Int J Ophthalmol, 2010, 3(4):299-303. DOI: 10.3980/j.issn.2222-3959.2010.04.05.
[19]
Chanut E, Labarthe B, Lacroix B, et al. Variations of dopamine,serotonin, and amino acid concentrations in Noda epileptic rat (NER) retina. Brain Res, 2006, 1070(1): 56-64. DOI: 10.1016/j.brainres.2005.11.032.
Ohngemach S, Hagel G, Schaeffel F. Concentrations of biogenic amines in fundal layers in chickens with normal visual experience, deprivation, and after reserpine application. Vis Neurosci, 1997, 14(3): 493-505.
[21]
Ohngemach S, Hagel G, Schaeffel F. Concentrations of biogenic amines in fundal layers in chickens with normal visual experience, deprivation, and after reserpine application. Vis Neurosci, 1997, 14(3): 493-505.
[22]
Guo SS, Sivak JG, Callender MG, et al. Retinal dopamine and lens-induced refractive errors in chicks. Curr Eye Res, 1995,14(5): 385-389.
Wu XH, Li YY, Zhang PP, et al. Unaltered retinal dopamine levels in a C57BL/6 mouse model of form-deprivation myopia.Invest Ophthalmol Vis Sci, 2015, 56(2): 967-977. DOI: 10.1167/iovs.13-13362.
[22]
Guo SS, Sivak JG, Callender MG, et al. Retinal dopamine and lens-induced refractive errors in chicks. Curr Eye Res, 1995,14(5): 385-389.
Wu XH, Li YY, Zhang PP, et al. Unaltered retinal dopamine levels in a C57BL/6 mouse model of form-deprivation myopia.Invest Ophthalmol Vis Sci, 2015, 56(2): 967-977. DOI: 10.1167/iovs.13-13362.
[25]
Li XX, Schaeffel F, Kohler K, et al. Dose-dependent effects of 6-hydroxy dopamine on deprivation myopia, electroretinograms,and dopaminergic amacrine cells in chickens. Vis Neurosci,1992, 9(5): 483-492.
[25]
Li XX, Schaeffel F, Kohler K, et al. Dose-dependent effects of 6-hydroxy dopamine on deprivation myopia, electroretinograms,and dopaminergic amacrine cells in chickens. Vis Neurosci,1992, 9(5): 483-492.
[26]
Diether S, Schaeffel F. Long-term changes in retinal contrast sensitivity in chicks from frosted occluders and drugs: Relations to myopia? Vision Res, 1999, 39(15): 2499-2510.
[26]
Diether S, Schaeffel F. Long-term changes in retinal contrast sensitivity in chicks from frosted occluders and drugs: Relations to myopia? Vision Res, 1999, 39(15): 2499-2510.
[27]
Lee JY, Djamgoz MB. Retinal dopamine depletion in young quail mimics some of the effects of aging on visual function.Vision Res, 1997, 37(9): 1103-1113.
[27]
Lee JY, Djamgoz MB. Retinal dopamine depletion in young quail mimics some of the effects of aging on visual function.Vision Res, 1997, 37(9): 1103-1113.
[28]
Wu XH, Qian KW, Xu GZ, et al. The role of retinal dopamine in C57BL/6 mouse refractive development as revealed by intravitreal administration of 6-Hydroxydopamine. Invest
Ophthalmol Vis Sci, 2016, 57(13): 5393-5404. DOI: 10.1167/iovs.16-19543.
[28]
Wu XH, Qian KW, Xu GZ, et al. The role of retinal dopamine in C57BL/6 mouse refractive development as revealed by intravitreal administration of 6-Hydroxydopamine. Invest
Ophthalmol Vis Sci, 2016, 57(13): 5393-5404. DOI: 10.1167/iovs.16-19543.